Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 15:28 ET | Source: NMDP

A Rockstar Puppet and a Life-Saving Message: NMDP Launches New Awareness Campaign to Help More Patients Receive Cell Therapy

NMDP launched a new PSA called "Know Your N-M-D-Ps,” featuring a puppet rock star, to raise awareness of blood stem cell transplants.
October 23, 2025 15:14 ET | Source: Gift of Life Marrow Registry

Leukemia Survivor Introduced to Lifesaving Donor by Former NFL Player at Boston College Donor Drive

A Boston College student body was witness to a profoundly emotional moment this week as a leukemia survivor met the stranger who saved his life.
September 09, 2025 08:30 ET | Source: Hairy Cell Leukemia Foundation

Hairy Cell Leukemia Foundation Celebrates 40th Anniversary

Hairy Cell Leukemia Foundation Celebrates 40 years of progress supporting the development and adoption of effective HCL treatments.
September 02, 2025 07:59 ET | Source: Research and Markets

Hemato-Oncology Testing Market Size, Share & Trends Analysis Report 2025-2030 Featuring Key Players Roche, Abbott, EntroGen, Qiagen, and Cepheid (Danaher) Among Others

Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The "Hemato-Oncology Testing Market Size, Share & Trends Analysis 2025-2030" has been added to ResearchAndMarkets.com's offering. The global hemato...
June 17, 2025 08:15 ET | Source: CERo Therapeutics Holdings, Inc.

CERo Therapeutics Holdings, Inc. Announces FDA Orphan Drug Designation Granted to CER-1236 for the Treatment of Acute Myeloid Leukemia (AML)

SOUTH SAN FRANSCISCO, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the...
May 16, 2025 16:48 ET | Source: NMDP

NMDP℠ Partners with Lil Miquela to Encourage Young People to Join the Blood Stem Cell Donor Registry and Help Save Patient Lives

NMDP partners with Lil Miquela, a 22-year-old virtual influencer with millions of fans, to grow NMDP Registry and help save patient lives.
March 20, 2025 16:05 ET | Source: Vor Biopharma

Vor Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update

VCAR33 clinical data update planned for first half of 2025 and trem-cel + Mylotarg clinical data update planned for second half of 2025 Anticipate initiation of the first trem-cel+VCAR33 Treatment...
December 10, 2024 07:00 ET | Source: IN8bio, Inc

IN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual Meeting

IN8bio Reports Continued Progression-Free Survival in Phase 1 Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 ASH Conference
December 06, 2024 08:00 ET | Source: Biomea Fusion, Inc.

Biomea Fusion to Host Conference Call to Present initial Clinical Data from Phase I COVALENT-103 Study of BMF-500, a Covalent FLT3 Inhibitor, in Relapsed or Refractory Acute Leukemia

REDWOOD CITY, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing oral...
December 03, 2024 07:30 ET | Source: Aptose Biosciences, Inc.

Aptose Signs CRADA with NCI to Develop Tuspetinib for AML and MDS in Newly Launched MyeloMATCH Precision Medicine Trials

Aptose's AML drug tuspetinib selected for NCI's prestigious clinical research program for ability to target broad spectrum of AML and MDS populations